Physician profile
Matthew Crowe
NPI 1952697898
$11,050.12
in general payments reported to CMS, 2019-2025
9 companies · $4,439 in 2025
The $4,439 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,998 · 2020: $1,043 · 2021: $285 · 2022: $1,280 · 2023: $153 · 2024: $853 · 2025: $4,439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,749 · Food and Beverage: $2,695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,748.97 |
| Food and Beverage | $2,695.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,497.25 | 2019-2025 | Arthrex |
| Team 1, LLC | $3,641.50 | 2022-2025 | |
| Stryker Corporation | $528.48 | 2021-2025 | Flexible Guide Pin (Stryker Acl Versitomic), Alphavent, Iconix |
| Zimmer Biomet Holdings, INC. | $412.25 | 2019-2025 | Juggerknotless Soft Anchor, Mymobility Platform, Rosa |
| Smith+Nephew, INC. | $391.06 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System |
| Exactech, INC. | $387.56 | 2024-2025 | |
| Bodycad USA Corp | $112.29 | 2024 | Fine Osteotomy |
| Vericel Corporation | $50.00 | 2024 | Maci |
| Moximed, INC | $29.73 | 2025 | Misha Knee System, Small, Left |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Crowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.